Monomorphic epitheliotropic intestinal T-cell lymphoma of the duodenum: an aggressive disease

Código QR

Monomorphic epitheliotropic intestinal T-cell lymphoma of the duodenum: an aggressive disease

Guardado en:

Detalles Bibliográficos
Autor principal:	Ganesh Kasinathan
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/4b93059d231b4f5c93f251cff054a386
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PROGNOSIS FACTORS IN AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH PRIMARY INVOLVEMENT OF THE SPLEEN
por: Larisa Musteata, et al.
Publicado: (2021)

Developments in anaplastic large-cell lymphoma: targeting the anaplastic lymphoma kinase
por: Farina F, et al.
Publicado: (2014)

Intrasinusoidal Hodgkin Lymphoma; A Mimic of Anaplastic Large Cell Lymphoma
por: John R. Krause, et al.
Publicado: (2021)

Peripheral T cell lymphoma: clinical utility of romidepsin
por: Sawey K, et al.
Publicado: (2012)

MicroRNAs as B-cell lymphoma biomarkers
por: Manterola L, et al.
Publicado: (2015)

Mogamulizumab for the treatment of adult T-cell leukemia/lymphoma
por: Yoshimitsu M, et al.
Publicado: (2014)

UPSHOTS IN ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA: ANALYSIS OF T-CELL BRAZIL PROJECT
por: Carlos CHIATTONE, et al.
Publicado: (2021)

Emerging role of SOX11 in mantle cell lymphoma
por: Kuci V, et al.
Publicado: (2015)

A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
por: Pınar Tığlıoğlu, et al.
Publicado: (2021)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013)

Immune targeted therapy for diffuse large B cell lymphoma
por: Yaxin Zheng, et al.
Publicado: (2021)

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
por: Ebru Pekgüç, et al.
Publicado: (2021)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

Advances in the diagnosis and management of lymphoma
por: Matasar MJ, et al.
Publicado: (2012)

MEDICAL TREATMENT IN HODGKIN LYMPHOMA
por: Nilgun Kurucu
Publicado: (2021)

THE SMALLEST PRIMARY BONE LYMPHOMA
por: Fatma Burçin KURTİPEK, et al.
Publicado: (2021)

Primary dural high grade B cell lymphoma mimicking subdural hematoma
por: Aya Nakaya, et al.
Publicado: (2021)

MYC as therapeutic target in leukemia and lymphoma
por: Cortiguera MG, et al.
Publicado: (2015)

ANTICARDIOLIPINIC ANTIBODIES IN NON-HODGKIN LYMPHOMA
por: Sanda Buruiana, et al.
Publicado: (2021)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

Treatment strategies for patients with diffuse large B-cell lymphoma: past, present, and future
por: Flowers CR, et al.
Publicado: (2012)

Preserving fertility in young patients with lymphoma: an overview
por: Patel B, et al.
Publicado: (2014)

THREE CASES WITH BURKITT LYMPHOMA PRESENTING WITH CHOLESTASIS
por: Fatma Tuba YILDIRIM, et al.
Publicado: (2021)

CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX
por: Senem MARAL, et al.
Publicado: (2021)

A CASE OF STAGE 1E DIFFUSE LARGE B-CELL LYMPHOMA PRESENTED WITH KNEE INVOLVEMENT
por: Mesut Tığlıoğlu, et al.
Publicado: (2021)

A CASE OF MULTI REGIONAL PRIMARY MUSCLE LYMPHOMA
por: Beyza OLUK, et al.
Publicado: (2021)

Yttrium-90 ibritumomab tiuxetan in the treatment of non-Hodgkin lymphoma
por: McKinney MS, et al.
Publicado: (2014)

Emerging targets in human lymphoma: targeting the MYD88 mutation
por: Wang JQ, et al.
Publicado: (2013)

BURKITT LYMPHOMA PRESENTING WITH EYE AND KIDNEY INVOLVEMENT: CASE REPORT
por: Aslı Turgutoğlu Yılmaz, et al.
Publicado: (2021)

Reduced intensity treatment in early-stage Hodgkin&rsquo;s lymphoma
por: Armitage JO, et al.
Publicado: (2011)

CAVITARY PRIMARY PULMONARY LYMPHOPLASMOCYTIC LYMPHOMA COMPLICATING HENOCH–SCHÖNLEIN PURPURA
por: Burak GULTEKIN, et al.
Publicado: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Julio Delgado, et al.
Publicado: (2021)

Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma
por: Illidge T, et al.
Publicado: (2012)

THE EFFECT OF COMORBIDITY AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MARGINAL ZONE LYMPHOMA
por: Esra TURAN ERKEK, et al.
Publicado: (2021)

The Use of Etoposide, Ara-Cytarabine, and Melphalan (EAM) Conditioning Chemotherapy in Autologous Stem Cell Transplantation (ASCT) for a Patient with Relapsed Hodgkin’s Lymphoma
por: Eko A. Pangarsa, et al.
Publicado: (2021)

Optimal management of endemic Burkitt lymphoma: a holistic approach mindful of limited resources
por: Moormann AM, et al.
Publicado: (2014)

mTOR inhibitor in the treatment of Hodgkin&rsquo;s lymphoma: a case report
por: Provencio M., et al.
Publicado: (2011)

CASE REPORT OF MARGINAL ZONE LYMPHOMA DETECTED WHILE INVESTIGATING ETIOLOGY FOR HEMOSTASIS DISORDER
por: Mesut Tığlıoğlu, et al.
Publicado: (2021)

Splenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management
por: Teixeira Mendes LS, et al.
Publicado: (2014)

Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment
por: Pujals A, et al.
Publicado: (2015)